首页> 美国卫生研究院文献>Mediators of Inflammation >A Traditional Chinese Medicine Xiao-Ai-Tong Suppresses Pain through Modulation of Cytokines and Prevents Adverse Reactions of Morphine Treatment in Bone Cancer Pain Patients
【2h】

A Traditional Chinese Medicine Xiao-Ai-Tong Suppresses Pain through Modulation of Cytokines and Prevents Adverse Reactions of Morphine Treatment in Bone Cancer Pain Patients

机译:中药小爱通通过调节细胞因子抑制疼痛并预防吗啡治疗骨癌疼痛患者的不良反应

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Treating cancer pain continues to possess a major challenge. Here, we report that a traditional Chinese medicine Xiao-Ai-Tong (XAT) can effectively suppress pain and adverse reactions following morphine treatment in patients with bone cancer pain. Visual Analogue Scale (VAS) and Quality of Life Questionnaire (EORTC QLQ-C30) were used for patient's self-evaluation of pain intensity and evaluating changes of adverse reactions including constipation, nausea, fatigue, and anorexia, respectively, before and after treatment prescriptions. The clinical trials showed that repetitive oral administration of XAT (200 mL, bid, for 7 consecutive days) alone greatly reduced cancer pain. Repetitive treatment with a combination of XAT and morphine (20 mg and 30 mg, resp.) produced significant synergistic analgesic effects. Meanwhile, XAT greatly reduced the adverse reactions associated with cancer and/or morphine treatment. In addition, XAT treatment significantly reduced the proinflammatory cytokines interleukin-1β and tumor necrosis factor-α and increased the endogenous anti-inflammatory cytokine interleukin-10 in blood. These findings demonstrate that XAT can effectively reduce bone cancer pain probably mediated by the cytokine mechanisms, facilitate analgesic effect of morphine, and prevent or reduce the associated adverse reactions, supporting a use of XAT, alone or with morphine, in treating bone cancer pain in clinic.
机译:治疗癌症疼痛仍然具有重大挑战。在这里,我们报告说,中成药小艾通(XAT)可以有效地抑制吗啡治疗后的骨癌疼痛患者的疼痛和不良反应。视觉模拟量表(VAS)和生活质量问卷(EORTC QLQ-C30)用于患者在处方治疗前后对疼痛强度的自我评估以及对便秘,恶心,疲劳和厌食等不良反应的变化。临床试验表明,单独重复口服XAT(200μmL,两次连续7天注射)可大大减轻癌症疼痛。 XAT和吗啡的组合(分别为20μmg和30μmg)的重复治疗产生了明显的协同镇痛作用。同时,XAT大大减少了与癌症和/或吗啡治疗相关的不良反应。此外,XAT治疗可显着降低血液中促炎细胞因子白细胞介素-1β和肿瘤坏死因子-α,并增加内源性抗炎细胞因子白细胞介素10。这些发现表明,XAT可以有效减轻可能由细胞因子机制介导的骨癌疼痛,促进吗啡的镇痛作用,并预防或减少相关的不良反应,从而支持XAT单独或与吗啡一起用于治疗骨痛。诊所。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号